Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,749 | -37,983 | -32,863 | -38,380 | -140,027 |
| Depreciation Amortization | 194,405 | 129,639 | 64,742 | 272,510 | 204,014 |
| Income taxes - deferred | 8,302 | -1,257 | 1,502 | -64,491 | 1,645 |
| Accounts receivable | 68,162 | 69,787 | 60,769 | -59,697 | 14,060 |
| Accounts payable and accrued liabilities | -3,338 | 11,554 | 6,416 | -4,593 | 30,119 |
| Other Working Capital | -85,442 | -20,798 | -10,862 | -93,399 | -89,967 |
| Other Operating Activity | 72,612 | -3,506 | -33,536 | 182,593 | 65,991 |
| Operating Cash Flow | $234,952 | $147,436 | $56,168 | $194,543 | $85,835 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,325 | -858 | -1,849 | 39,653 | 8,543 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -12,000 | -12,000 |
| Other Investing Activity | 0 | 0 | 0 | -12,000 | -12,000 |
| Investing Cash Flow | $-5,325 | $-858 | $-1,849 | $27,653 | $-3,457 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,107,435 | 517,378 | N/A | 818,026 | N/A |
| Debt Repayment | -1,732,601 | -1,076,308 | -300,000 | -845,749 | -27,723 |
| Common Stock Issued | 348,497 | 344,287 | 337,792 | 25,582 | 14,464 |
| Other Financing Activity | -26,163 | -24,374 | -17,171 | -14,455 | -12,882 |
| Financing Cash Flow | $-302,832 | $-239,017 | $20,621 | $-16,596 | $-26,141 |
| Exchange Rate Effect | -1,202 | 58 | -518 | -1,380 | -688 |
| Beginning Cash Position | 962,117 | 962,117 | 962,117 | 757,897 | 757,897 |
| End Cash Position | 887,710 | 869,736 | 1,036,539 | 962,117 | 813,446 |
| Net Cash Flow | $-74,407 | $-92,381 | $74,422 | $204,220 | $55,549 |
| Free Cash Flow | |||||
| Operating Cash Flow | 234,952 | 147,436 | 56,168 | 194,543 | 85,835 |
| Capital Expenditure | -11,325 | -6,858 | -1,849 | -4,771 | -881 |
| Free Cash Flow | 223,627 | 140,578 | 54,319 | 189,772 | 84,954 |